140 Scott Drive Menlo Park, California 94025 Tel: +1.650.328.4600 Fax: +1.650.463.2600 www.lw.com
| ||||
July 20, 2020
VIA EDGAR AND ELECTRONIC MAIL |
FIRM / AFFILIATE OFFICES | |||
Beijing Boston Brussels Century City Chicago Dubai Düsseldorf Frankfurt Hamburg Hong Kong Houston London Los Angeles Madrid Milan |
Moscow Munich New York Orange County Paris Riyadh San Diego San Francisco Seoul Shanghai Silicon Valley Singapore Tokyo Washington, D.C. |
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: | Deanna Virginio |
Joseph McCann |
Mary Mast |
Angela Connell |
Re: | Annexon, Inc. |
Responses to Letter dated July 16, 2020 |
Registration Statement on Form S-1 |
CIK No. 0001528115 |
Ladies and Gentlemen:
Annexon, Inc. (the Company) has filed with the U.S. Securities and Exchange Commission (the Commission) on the date hereof an amended Registration Statement (Amendment No. 1) on Form S-1. The Company previously filed with the Commission a Registration Statement on Form S-1 (the Initial Filing). The Registration Statement has been revised to reflect the Companys responses to the comment letter to the Initial Filing received on July 16, 2020 from the staff of the Commission (the Staff), and we are hereby providing the Companys responses to the Staffs letter. For your convenience, we are also providing by electronic mail a courtesy package that includes two copies of Amendment No. 1, one of which has been marked to show changes from the Initial Filing, as well as a copy of this letter.
For ease of review, we have set forth below each of the numbered comments of the Staffs letter dated July 16, 2020 in bold type followed by the Companys responses thereto.
July 20, 2020
Page 2
Registration Statement on Form S-1 filed July 2, 2020
Business, page 102
1. | We note your disclosure on page 104 states that you observed that early decline in NfL significantly correlated with improvement in the GBS-DS at the end of the study. We also note that the correlation coefficient included in the graph on pg. 104 is equal to 0.431. Please revise your description of the correlation coefficient to explain how the value obtained places it in the range of no correlation to perfect correlation and how you determined the variables were significantly correlated. |
Response: The Company respectfully acknowledges the Staffs comment and has revised the disclosure on page 107 of Amendment No. 1 accordingly. In particular, the Company has removed the inclusion of the descriptor significantly in regards to the correlation and has added the reference to the p-value measure of correlation of < 0.05, which is generally considered statistically significant, in the aforementioned text. The Company respectfully advises the Staff that the explanation of the value of r (the reference for correlation coefficient) is included in the text immediately below the applicable graphic on page 107, and the Company has included additional language in the explanation with regard to the 0.431 correlation coefficient.
Managements Discussion and Analysis
Critical Accounting Policies and Estimates
Stock Compensation, page 88
2. | You issued 71,719,859 shares of Series D redeemable convertible preferred stock in June 2020 at $1.4222 per share. In light of your valuation of your common stock during June 2020 and your anticipated IPO price, please tell us your consideration of recording a beneficial conversion feature in the second quarter 2020 pursuant to ASC 470-20, and if material, confirm you will disclose in the filing, prior to going effective, the anticipated beneficial conversion feature that will be recorded. Please consider discussing in your response any preferences related to the preferred shares that may affect the determination of any beneficial conversion feature and how you considered those preferences in your evaluation. |
Response: The Company respectfully acknowledges the Staffs comment and has revised the disclosure on page 89 of Amendment No. 1 accordingly.
* * *
July 20, 2020
Page 3
We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (650) 463-3014 or by fax at (650) 463-2600 with any questions or comments regarding this correspondence.
Very truly yours,
/s/ Brian J. Cuneo
Brian J. Cuneo
of LATHAM & WATKINS LLP
cc: | Douglas Love, Annexon, Inc. |
Jennifer Lew, Annexon, Inc. Kathleen Wells, Latham & Watkins LLP |
Charles Kim, Cooley LLP |
Kristin VanderPas, Cooley LLP |
Michael Tenta, Cooley LLP |
David Peinsipp, Cooley LLP |